PuSH - Publikationsserver des Helmholtz Zentrums München

Strauß, T.* ; Marvian-Tayaranian, A.* ; Sadikoglou, E.* ; Dhingra, A.* ; Wegner, F.* ; Trümbach, D. ; Wurst, W. ; Heutink, P.* ; Schwarz, S.C.* ; Höglinger, G.U.*

iPS cell-based model for MAPT Haplotype as a risk factor for human tauopathies identifies no major differences in TAU expression.

Front. Cell Dev. Biol. 9:726866 (2021)
Verlagsversion Forschungsdaten DOI
Open Access Gold
Creative Commons Lizenzvertrag
The H1 haplotype of the microtubule-associated protein tau (MAPT) gene is a common genetic risk factor for some neurodegenerative diseases such as progressive supranuclear palsy, corticobasal degeneration, and Parkinson’s disease. The molecular mechanism causing the increased risk for the named diseases, however, remains unclear. In this paper, we present a valuable tool of eight small molecule neural precursor cell lines (smNPC) homozygous for the MAPT haplotypes (four H1/H1 and four H2/H2 cell lines), which can be used to identify MAPT-dependent phenotypes. The employed differentiation protocol is fast due to overexpression of NEUROGENIN-2 and therefore suitable for high-throughput approaches. A basic characterization of all human cell lines was performed, and their TAU and α-SYNUCLEIN profiles were compared during a differentiation time of 30 days. We could identify higher levels of conformationally altered TAU in cell lines carrying the H2 haplotype. Additionally, we found increased expression levels of α-SYNUCLEIN in H1/H1 cells. With this resource, we aim to fill a gap in neurodegenerative disease modeling with induced pluripotent stem cells (iPSC) for sporadic tauopathies.
Weitere Metriken?
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Disease Modeling ; Ipsc ; Mapt Haplotype ; Ngn2 Neurons ; Tau ; α-synuclein; Progressive Supranuclear Palsy; Alpha-synuclein Gene; Mapt H1 Haplotype; Parkinsons-disease; Association Analysis; Protein-tau; Dementia; Snca; Alzheimers; Pathology
ISSN (print) / ISBN 2296-634X
e-ISSN 2296-634X
Quellenangaben Band: 9, Heft: , Seiten: , Artikelnummer: 726866 Supplement: ,
Verlag Frontiers
Verlagsort Lausanne
Begutachtungsstatus Peer reviewed
Förderungen university library of the Technical University Munich
Petermax-Muller Foundation (Etiology and Therapy of Synucleinopathies and Tauopathies)
VolkswagenStiftung/Lower Saxony Ministry for Science (Niedersachsisches Vorab)
Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy within the Munich Cluster for Systems Neurology
German Federal Ministry of Education and Research